awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35540000-02A4AC3F-B09D-407D-86FE-6B5D51D5D168
Q35540000-02A4AC3F-B09D-407D-86FE-6B5D51D5D168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35540000-02A4AC3F-B09D-407D-86FE-6B5D51D5D168
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
P2860
Q35540000-02A4AC3F-B09D-407D-86FE-6B5D51D5D168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35540000-02A4AC3F-B09D-407D-86FE-6B5D51D5D168
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f7f84f6a2701473a709b352a58c2be1654dab983
P2860
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.